Q2 2021 Holdings
Filed 2021-08-16 | 58 holdings | $341.1M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2021-08-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $172.6M | 3,156,981 | 50.6% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $32.4M | 850,000 | 9.5% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $29.0M | 989,095 | 8.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $27.7M | 1,400,000 | 8.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $21.7M | 715,000 | 6.4% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $18.1M | 1,162,320 | 5.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $11.9M | 675,000 | 3.5% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $11.5M | 1,420,500 | 3.4% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $7.4M | 288,458 | 2.2% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $4.3M | 112,928 | 1.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $3.6M | 159,622 | 1.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $104.8K | 3,743,875 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $54.3K | 2,732,501 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $45.7K | 758,265 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $43.2K | 2,054,392 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $40.3K | 1,100,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $37.0K | 325,000 | 0.0% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $32.9K | 1,070,762 | 0.0% |
| Instil BIO Inc | COM | 45783C101 | $32.8K | 1,696,850 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $31.8K | 1,002,382 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $31.2K | 400,000 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $31.0K | 1,329,602 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $30.2K | 1,215,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $29.3K | 1,125,000 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $26.3K | 1,231,812 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR)Call | COM | 75382E109 | $23.8K | 750,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $22.1K | 350,000 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $20.9K | 939,545 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $15.8K | 2,500,000 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $15.7K | 724,333 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $14.4K | 1,410,812 | 0.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $13.7K | 547,122 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $12.5K | 2,300,000 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $12.1K | 780,331 | 0.0% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $11.5K | 400,000 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $11.1K | 800,000 | 0.0% |
| Harpoon Therapeutics Inc | COM | 41358P106 | $11.1K | 800,000 | 0.0% |
| Eledon Pharmaceuticals Inc(ELDN)A | COM | 28617K101 | $10.6K | 1,339,793 | 0.0% |
| Landos Biopharma Inc | COM | 515069102 | $10.4K | 899,106 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $10.3K | 330,000 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $8.6K | 270,000 | 0.0% |
| Talaris Therapeutics Inc | COM | 87410C104 | $7.5K | 507,923 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $7.1K | 206,564 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $6.8K | 300,000 | 0.0% |
| Catabasis Pharmaceuticals in(CATBEUR) | COM NEW | 14875P206 | $6.7K | 3,190,000 | 0.0% |
| Aslan Pharmaceuticals LTD | ADS | 04522R101 | $6.6K | 2,000,000 | 0.0% |
| Aligos Therapeutics Inc | COM | 01626L105 | $4.3K | 212,785 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $4.2K | 299,853 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $2.3K | 200,000 | 0.0% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $2.1K | 200,000 | 0.0% |